NCT04349215View on ClinicalTrials.gov

Validation of the Chinese ObsQoR-11

CompletedOBSERVATIONAL
Enrollment

319

Participants

Timeline

Start Date

March 9, 2020

Primary Completion Date

March 10, 2022

Study Completion Date

March 10, 2022

Conditions
Cesarean Delivery
Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT04349215 - Validation of the Chinese ObsQoR-11 | Biotech Hunter | Biotech Hunter